Summary: The clinical application and therapeutic use of stem cells has become a hot research topic for the scientific community and a potentially lucrative area for the medical industry that hope to find new treatments for cancer and other debilitating diseases. With the beginning of a new year, this is a highlight of several biotechnology/biopharmaceutical companies with promising therapies that utilize mesenchymal stem cells and are in Phase III clinical trials. Read More

November 30, 2011 – The National Institutes of Health (NIH) awarded InVitria a $725,000 Phase II, Small Business Innovation Research (SBIR) Grant to broaden the applications for InVitria’s recombinant human serum albumin product Cellastim®... read more